ADAR1 Capital Management

ADAR1 Capital Management

Signal active

Investment Firm

Overview

ADAR1 Capital Management is an investment firm.

Highlights

Founded

Invalid date

Industry

Employees

0

Investment

3

Lead Investment

0

Exits

1

Stages

N/A

Investor Type

N/A

Location

N/A

Contact Information

Social

Profile Resume

ADAR1 Capital Management, established in Unknown year., specializes in investments across Biotechnology, Health Care, Therapeutics, Financial Services, Venture Capital, Finance, Pharmaceutical, Medical, Robotics, Genetics. The organization boasts a portfolio of 1 investments, with an average round size of $42.5M and 1 successful exits. Their recent investments include Tenax Therapeutics, Vivo Capital, Kala Pharmaceuticals, SR One, iBio. The highest investment round they participated in was $910.0M. Among their most notable exits are Tenax Therapeutics and Vivo Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

N/A

Investment portfolio

ADAR1 Capital Management has made 3 investments. Their most recent investment was on Aug 06, 2024, when Tenax Therapeutics raised $100.0M.

investments

3

Diversity investments

0

Lead investments

0

Number of exits

1

Investments

3

Annouced DateOrganization NameIndustryMoney Raised
Mar 26, 2024
iBio iBio
Biotechnology15.0M
Jun 27, 2024
Kala Pharmaceuticals Kala Pharmaceuticals
Biotechnology12.5M
Aug 06, 2024
Tenax Therapeutics Tenax Therapeutics
Biotechnology100.0M

Exits

1

Funding Timeline

Funding rounds

3

Investors

0

Funds

0

Funding Rounds

3

ADAR1 Capital Management has raised 3 rounds. Their latest funding was raised on Aug 06, 2024 from a Post-IPO Equity - Tenax Therapeutics round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Mar 26, 2024
Post-IPO Equity - iBio Post-IPO Equity - iBio
-15.0M-
Jun 27, 2024
Post-IPO Equity - Kala Pharmaceuticals Post-IPO Equity - Kala Pharmaceuticals
-12.5M-
Aug 06, 2024
Post-IPO Equity - Tenax Therapeutics Post-IPO Equity - Tenax Therapeutics
-100.0M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

N/A

Recent Activity

There is no recent news or activity for this profile.